ELEVANCE HEALTH INC (ELV)
US0367521038 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to ELV. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 589.78. This target is 9.28% above the current price.
ELV was analyzed by 26 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ELV.
In the previous month the buy percentage consensus was at a similar level.
ELV was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-24 | Mizuho | Maintains | Buy -> Buy |
| 2024-04-19 | UBS | Maintains | Buy -> Buy |
| 2024-04-19 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-04-19 | Barclays | Maintains | Overweight -> Overweight |
| 2024-04-19 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-04-19 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-04-19 | Jefferies | Maintains | Buy -> Buy |
| 2024-04-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-04-08 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-04-04 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-03-06 | Barclays | Initiate | Overweight |
| 2024-02-14 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2024-02-02 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-01-25 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-01-25 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-01-19 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-11-21 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-11-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-10-19 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-10-19 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-09-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-07-25 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-07-24 | TD Cowen | Maintains | Outperform -> Outperform |
| 2023-07-20 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-07-20 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2023-07-13 | UBS | Maintains | Buy -> Buy |
| 2023-07-12 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2023-07-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-06-20 | Truist Securities | Maintains | Buy -> Buy |
| 2023-04-27 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |